[go: up one dir, main page]

ECSP13012798A - METHOD FOR INHIBITING PATHOGENS USING A NUTRITIONAL COMPOSITION - Google Patents

METHOD FOR INHIBITING PATHOGENS USING A NUTRITIONAL COMPOSITION

Info

Publication number
ECSP13012798A
ECSP13012798A ECSP13012798A ECSP13012798A EC SP13012798 A ECSP13012798 A EC SP13012798A EC SP13012798 A ECSP13012798 A EC SP13012798A EC SP13012798 A ECSP13012798 A EC SP13012798A
Authority
EC
Ecuador
Prior art keywords
nutritional composition
inhibiting pathogens
inhibiting
human
source
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Robert J Mcmahon
Anja Wittke
Cecilia Munoz
Dattatreya Banavara
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,813 external-priority patent/US8648036B2/en
Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of ECSP13012798A publication Critical patent/ECSP13012798A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pediatric Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un método para inhibir un mecanismo bacteriano invasivo o de adhesión que involucra el administrar a un humano una composición nutricional que incluye un lípido o grasa; una fuente de proteína; una composición prebiótica; y al menos aproximadamente 10 mg/100 kCal de lactoferrinas producidas por una fuente no humana.A method for inhibiting an invasive or adhesion bacterial mechanism that involves administering to a human a nutritional composition that includes a lipid or fat; a source of protein; a prebiotic composition; and at least about 10 mg / 100 kCal of lactoferrins produced by a non-human source.

ECSP13012798 2010-12-29 2013-07-29 METHOD FOR INHIBITING PATHOGENS USING A NUTRITIONAL COMPOSITION ECSP13012798A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/980,813 US8648036B2 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US12/980,808 US20120171163A1 (en) 2010-12-29 2010-12-29 Method for inhibiting a bacterial invasive mechanism using a nutritional composition

Publications (1)

Publication Number Publication Date
ECSP13012798A true ECSP13012798A (en) 2013-09-30

Family

ID=45496273

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012798 ECSP13012798A (en) 2010-12-29 2013-07-29 METHOD FOR INHIBITING PATHOGENS USING A NUTRITIONAL COMPOSITION

Country Status (13)

Country Link
EP (1) EP2658388A2 (en)
CN (1) CN103327828B (en)
BR (1) BR112013011642B1 (en)
CA (1) CA2822892C (en)
EC (1) ECSP13012798A (en)
MX (1) MX2013006094A (en)
MY (1) MY174494A (en)
PE (1) PE20141192A1 (en)
PH (1) PH12013500916A1 (en)
RU (1) RU2013128920A (en)
SG (2) SG190781A1 (en)
TW (1) TWI626893B (en)
WO (1) WO2012091946A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
PL2934188T3 (en) * 2012-12-18 2018-09-28 Mjn U.S. Holdings Llc Milk-based nutritional compositions containing lactoferrin and uses thereof
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20200276321A1 (en) * 2017-09-10 2020-09-03 Technion Research & Development Foundation Limited Composition and method for a prebiotic delivery system targeted to probiotic bacteria
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide
CN120051217A (en) 2022-09-14 2025-05-27 N·V·努特里奇亚 Nutritional composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
CA2101274C (en) 1991-01-24 1998-12-15 David J. Kyle Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
JPH09509165A (en) 1994-02-16 1997-09-16 ファーミング ベスローテン フェンノートシャップ Separation of lactoferrin from milk
EP1480524B1 (en) 2002-03-07 2013-04-17 Upfront Chromatography A/S A process of isolating lactoferrin
CN101247823A (en) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 Use of bovine lactoferrin in the preparation of medicines for inhibiting bacterial growth
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
MY160434A (en) * 2007-11-26 2017-03-15 Nestec Sa Age-tailored nutrition system for infants
ITRM20080163A1 (en) * 2008-03-26 2009-09-27 Maurizio Acri USE OF LATTOFERRINA FOR THE PREVENTION OF NEONATAL SEPSIS IN PREMATURED NEWBORNS
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
CN102724886A (en) * 2009-10-29 2012-10-10 雀巢产品技术援助有限公司 Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof

Also Published As

Publication number Publication date
HK1189456A1 (en) 2014-06-13
SG10201508194RA (en) 2015-11-27
TWI626893B (en) 2018-06-21
CN103327828B (en) 2016-05-11
CA2822892A1 (en) 2012-07-05
TW201238503A (en) 2012-10-01
RU2013128920A (en) 2015-02-10
WO2012091946A2 (en) 2012-07-05
EP2658388A2 (en) 2013-11-06
BR112013011642B1 (en) 2020-04-07
BR112013011642A2 (en) 2016-07-12
CN103327828A (en) 2013-09-25
SG190781A1 (en) 2013-07-31
MY174494A (en) 2020-04-23
MX2013006094A (en) 2013-07-03
PH12013500916A1 (en) 2024-06-03
PE20141192A1 (en) 2014-10-01
WO2012091946A3 (en) 2012-09-07
CA2822892C (en) 2020-04-28

Similar Documents

Publication Publication Date Title
ECSP13012798A (en) METHOD FOR INHIBITING PATHOGENS USING A NUTRITIONAL COMPOSITION
BR112012011478A2 (en) concentrated therapeutic phospholipid compositions.
EA201070419A1 (en) COMPOSITION FOR REGULATING METABOLISM OF LIPIDS
BR112015014420A2 (en) human milk oligosaccharides to improve stress symptoms
BR112013025974A2 (en) feed product comprising different layers
CL2013002210A1 (en) Prebiotic formulation for human consumption comprising 2'-fucosylactose, 3'-sialylactose and 6'-sialylactose, in which the amount by weight of 3'-sialylactose is at least as high as the amount of 2'-fucosylactose; and method to modulate or stimulate the proliferation of bifidobacteria in the human intestine.
BR112012032816A2 (en) controlled release pharmaceutical composition, and methods for reducing the dietary effect of a controlled release composition, reducing the amount of time required to achieve a stable state for metformin, to improve the bioavailability of a controlled release dosage form. matrix
PH12014500558A1 (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
MX2022011742A (en) NUTRITIONAL COMPOSITION FOR THE GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE.
BR112015029987A8 (en) A2 beta-casein and the prevention of intestinal inflammation
BR112014027820A2 (en) dietary control of celiac disease and food allergies
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
ECSP13012799A (en) USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS
BR112014015354A8 (en) composition of elagitanine enriched extracts on sexual well-being
MX382215B (en) COMPOSITIONS FOR USE IN DISEASES INVOLVING THE ACCUMULATION OF FAT IN TISSUES.
ZA201404537B (en) Method and composition for increasing the proportion of dietary ingredients that are resistant to degradation by ruminal microorganisms
BR112014007328A2 (en) chewable food compositions
BR112013027474A2 (en) compositions that improve palatability
WO2010119424A3 (en) Composition for regulating the metabolism of lipids
PE20151498A1 (en) NUTRITIONAL COMPOSITION TO PROMOTE SATIETY
BR112012016054A2 (en) Nutritional compositions comprising fruit flakes including docosahexaenoic acid
MX2014001767A (en) Methods for ameliorating symptoms or conditions caused by stress.
BR112012024214A2 (en) method for improving the palatability of edible compositions.
BR112014003545A8 (en) method to turn a meal
BR112012021710A2 (en) marinades for meat and seafood containing natural metabolism.